SCHEMBL17034997

SCHEMBL17034997

c1ccc(-c2nc3ccccc3c3c2cc(-c2cccc(-c4cc5ccccc5c5c4oc4ccc6ccccc6c45)c2)c2ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.38
CYP1A1 P04798 1/20 0.38
CYP1A2 P05177 1/20 0.38
FYN P06241 1/20 0.38
MAPK3 P27361 1/20 0.38
AHR P35869 1/20 0.38
PAX8 Q06710 1/20 0.38
MAPT P10636 6/20 0.36
ALDH1A1 P00352 6/20 0.36
HPGD P15428 5/20 0.36
KDM4E B2RXH2 3/20 0.36
HSD17B10 Q99714 3/20 0.36
TSHR P16473 2/20 0.36
CASP1 P29466 2/20 0.36
ALOX15 P16050 1/20 0.36
CASP7 P55210 1/20 0.36
KMT2A Q03164 4/20 0.34
MAPK1 P28482 2/20 0.34
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17034996 0.94 ABCG2 (0.39) ABCG2CYP1A1CYP1A2FYNMAPK3
SCHEMBL17035082 0.92 ABCG2 (0.38) ABCG2CYP1A1CYP1A2FYNMAPK3
SCHEMBL18907210 0.92 ABCG2 (0.38) ABCG2CYP1A1CYP1A2FYNMAPK3
SCHEMBL17034931 0.91 ABCG2 (0.40) ABCG2CYP1A1CYP1A2FYNMAPK3
SCHEMBL18907212 0.89 CYP1A2 (0.37) ABCG2CYP1A1CYP1A2FYNMAPK3
SCHEMBL17035026 0.88 CYP11B1 (0.43) ABCG2CYP1A1CYP1A2FYNMAPK3
SCHEMBL17035043 0.88 ABCG2 (0.38) ABCG2CYP1A1CYP1A2FYNMAPK3
SCHEMBL17035079 0.88 ABCG2 (0.38) ABCG2CYP1A1CYP1A2FYNMAPK3
SCHEMBL18907198 0.87 ABCG2 (0.37) ABCG2CYP1A1CYP1A2FYNMAPK3
SCHEMBL19009704 0.87 ABCG2 (0.37) ABCG2CYP1A1CYP1A2FYNMAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ABCG2 4363/4885CYP1A1 495/4885CYP1A2 1306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.